A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations. (Date:05/18/2018 14:43) Read full article >>

Related News about "Improving survival in pancreatic cancer with platinum-based chemotherapy" news from other sites: (news similarity rate is shown on left.)

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda.      (Photo: >>
Cxbladder™ Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC) The addition of Cxbladder Monitor for bladder cancer surveillance has been shown to enable physicians to reduce the overall number of diagnostic tests being ordered, potentially reducing the total cos.. >>
Targovax Strengthens 2-year Survival Rate in Resected Pancreatic Cancer With TG01 Targovax ASA ("Targovax" or "the Company") (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces the completion of the 32-patien.. >>
New Review of DNA Damage Response - An Emerging Target for Groundbreaking Cancer Therapies - touchONCOLOGY Sean Bohen, Mark J O'Connor, Meredith Morgan European Oncology & Haematology. 2018;14(Suppl 1):2-7 >>
'I was unlucky but you're not': Breast cancer victim's heartbreaking goodbye letter Vanessa Juressic's final words moved a packed church to tears when read by her best friend at her funeral in Sydney on Friday. She died of breast cancer on May 11 after a 15-month battle... >>